|
|
regionalization
|
GO:0003002 |
337 |
0.747
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.592
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.516
|
Zebrafish |
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.481
|
|
|
|
prechordal plate formation
|
GO:0021501 |
1 |
0.466
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.332
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.315
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.314
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.308
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.302
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.302
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.302
|
Zebrafish |
|
|
left lung morphogenesis
|
GO:0060460 |
3 |
0.272
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.223
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.223
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.222
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.219
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.214
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.200
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.200
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.199
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.188
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.187
|
Zebrafish |
|
|
gastrulation
|
GO:0007369 |
116 |
0.185
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.178
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.178
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.176
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.175
|
|
|
|
regulation of nodal signaling pathway
|
GO:1900107 |
4 |
0.172
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.170
|
Zebrafish |
|
|
epidermis development
|
GO:0008544 |
187 |
0.170
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.169
|
Zebrafish |
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.169
|
Zebrafish |
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.162
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.162
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.162
|
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.161
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.160
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.159
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.155
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.154
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.154
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.147
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.142
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.142
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.140
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.138
|
Zebrafish |
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.137
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.137
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.132
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.129
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.126
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.123
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.122
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.121
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.121
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.118
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.116
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.115
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.114
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.113
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.113
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.112
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.112
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.111
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.109
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.108
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.107
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.107
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.106
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.106
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.105
|
|
|
|
negative regulation of nodal signaling pathway
|
GO:1900108 |
3 |
0.103
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.103
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.102
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.101
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.101
|
|
|
|
axial mesodermal cell fate specification
|
GO:0048327 |
1 |
0.099
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.097
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.097
|
|
|
|
floor plate morphogenesis
|
GO:0033505 |
3 |
0.097
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.096
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.096
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.096
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.096
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.096
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.095
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.095
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.094
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.093
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.092
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.092
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.090
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.088
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.088
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.088
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.088
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.087
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.087
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.087
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.087
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.086
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.086
|
|
|
|
nodal signaling pathway
|
GO:0038092 |
10 |
0.086
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.086
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.085
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.085
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.085
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.084
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.084
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.083
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.082
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.082
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.081
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.081
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.081
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.080
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.079
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.076
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.075
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.074
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.073
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.073
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.073
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.073
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.072
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.071
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.070
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.070
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.069
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.068
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.068
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.068
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.067
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.067
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.067
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.067
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.066
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.066
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.065
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.065
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.065
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.064
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.064
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.063
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.063
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.063
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.063
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.063
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.062
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.062
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.062
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.061
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.061
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.061
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.060
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.060
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.060
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.060
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.060
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.060
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.060
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.060
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.060
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.058
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.058
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.057
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.057
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.057
|
|
|
|
floor plate formation
|
GO:0021508 |
2 |
0.057
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.057
|
|
|
|
ventral midline development
|
GO:0007418 |
4 |
0.057
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.057
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.056
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.056
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.055
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.055
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.055
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.054
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.054
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.054
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.054
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.054
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.053
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.053
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.053
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.053
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.052
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.052
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.052
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.052
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.052
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.052
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.052
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.051
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.050
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.050
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.050
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.050
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.050
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.049
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.049
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.049
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.049
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.049
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.048
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.048
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.048
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.048
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.048
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.047
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.047
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.047
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.047
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.047
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.047
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.046
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.046
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.046
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.046
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.046
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.046
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.045
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.045
|
|
|
|
embryonic heart tube anterior posterior pattern specification
|
GO:0035054 |
3 |
0.045
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.045
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.045
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.045
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.045
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.045
|
|
|
|
determination of digestive tract left right asymmetry
|
GO:0071907 |
1 |
0.045
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.044
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.044
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.044
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.044
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.044
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.044
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.044
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.044
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.044
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.043
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.043
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.043
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.043
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.043
|
|
|
|
positive regulation of dna endoreduplication
|
GO:0032877 |
2 |
0.043
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.042
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.042
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.042
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.042
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.042
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.042
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.041
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.041
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.041
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.041
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.041
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.041
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.040
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.040
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.040
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.040
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.040
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.040
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.040
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.040
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.040
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.039
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.039
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.039
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.039
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.039
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.039
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.038
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.038
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.038
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.038
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.038
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.038
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.038
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.038
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.038
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.038
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.037
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.037
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.037
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.037
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.037
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.037
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.037
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.037
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.036
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.036
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.036
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.036
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.036
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.036
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.036
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.036
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.035
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.035
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.035
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.035
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.035
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.035
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.035
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.035
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.034
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.034
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.034
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.034
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.034
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.034
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.034
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.034
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.034
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.034
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.034
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.034
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.034
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.034
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.034
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.034
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.033
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.033
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.033
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.033
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.033
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.033
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.033
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.033
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.033
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.033
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.033
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.033
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.032
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.032
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.032
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.032
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.032
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.032
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.032
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.032
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.032
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.032
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.032
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.032
|
|
|
|
renal capsule morphogenesis
|
GO:0072128 |
1 |
0.032
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.032
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.032
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.032
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.032
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.031
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.031
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.031
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.031
|
Zebrafish |
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.031
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.031
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.031
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.031
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.030
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.030
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.030
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.030
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.030
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.030
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.030
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.030
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.030
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.030
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.029
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.029
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.029
|
|
|
|
left right pattern formation
|
GO:0060972 |
23 |
0.029
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.029
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.029
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.029
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.029
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.029
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.029
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.029
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.029
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.029
|
|
|
|
axial mesoderm development
|
GO:0048318 |
8 |
0.029
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.029
|
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.028
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.028
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.028
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.028
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.028
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.028
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.028
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.028
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.028
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.028
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.027
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.027
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.027
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.027
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.027
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.027
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.027
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.027
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.027
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.027
|
|
|
|
positive regulation of transcription from rna polymerase iii promoter
|
GO:0045945 |
1 |
0.027
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.027
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.027
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.027
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.027
|
|
|
|
trachea formation
|
GO:0060440 |
3 |
0.027
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.027
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.027
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.026
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.026
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
2 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.026
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.026
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.026
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.026
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.026
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.026
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.026
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.026
|
|
|
|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902256 |
2 |
0.026
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.026
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.026
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.026
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.026
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.025
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.025
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.025
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.025
|
|
|
|
regulation of transcription by glucose
|
GO:0046015 |
3 |
0.025
|
|
|
|
female somatic sex determination
|
GO:0019101 |
1 |
0.025
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.025
|
|
|
|
renal vesicle morphogenesis
|
GO:0072077 |
15 |
0.025
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.025
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.025
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
17 |
0.025
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.025
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.025
|
|
|
|
negative regulation of hexokinase activity
|
GO:1903300 |
4 |
0.025
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.025
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.025
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.025
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.025
|
|
|
|
negative regulation of receptor activity
|
GO:2000272 |
5 |
0.025
|
|
|
|
somite rostral caudal axis specification
|
GO:0032525 |
13 |
0.024
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.024
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.024
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.024
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.024
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.024
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.024
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.024
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.024
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.024
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.024
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.024
|
|
|
|
hypothalamus cell migration
|
GO:0021855 |
5 |
0.024
|
|
|
|
secondary heart field specification
|
GO:0003139 |
6 |
0.024
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.024
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.024
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.024
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.024
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.024
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.024
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.023
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.023
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.023
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.023
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.023
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.023
|
|
|
|
carbon catabolite regulation of transcription from rna polymerase ii promoter
|
GO:0000429 |
4 |
0.023
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.023
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.023
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.023
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.023
|
|
|
|
metanephric collecting duct development
|
GO:0072205 |
7 |
0.023
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.023
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.023
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.023
|
|
